(-)-Epigallocatethin-3-O-gallate counteracts caffeine-induced hyperactivity: Evidence of dopaminergic blockade

Behavioural Pharmacology

Volumn 21, Issue 5-6, 2010, Pages 572-575

  Park, Kwang Soon ^a   Eun, Jae Soon ^b   Kim, Hyoung Chun ^c   Moon, Dong Cheul ^a   Hong, Jin Tae ^a   Oh, Ki Wan ^a  

^a Chungbuk National University   (South Korea)

^b Woosuk University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

( ) epigallocatethin 3 O gallate; Caffeine; dopamine receptors; hyperactivity; mouse; psychostimulant

Indexed keywords

APOMORPHINE; CAFFEINE; COCAINE; DOPAMINE RECEPTOR; EPIGALLOCATECHIN GALLATE; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CLIMBING; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; REARING; STEREOTYPY; STIMULATION; TEA;

ANIMALS; CAFFEINE; CATECHIN; CENTRAL NERVOUS SYSTEM STIMULANTS; HYPERKINESIS; MALE; MICE; MICE, INBRED ICR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STEREOTYPED BEHAVIOR; TEA;

EID: 77955981398     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833beffb     Document Type: Article

References (31)

1. Adachi N, Tomonaga S, Tachibana T, Denbow DM, Furuse M (2006). (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531:171-175.
2. Angelucci F, Ricci V, Spalletta G, Caltagirone C, Aleksander A, Bria MP (2009). Effects of psychostimulants on neurotrophins: implications for psychostimu-lant-induced neurotoxicity. Int Rev Neurobiol 88:1-24.
3. Antoniou K, Kafetzopoulos E, Papadopoulou-Daifoti Z, Hyphantis T, Marselos M (1998). D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioral patterens in rats. Neurosci Behavl Rev 23:189-196.
4. Bae JH, Mun KC, Park WK, Lee SR, Suh SI, Baek WK, et al. (2002). EGCG attenuates AMPA-induced intracellular calcium increase in hippocampal neurons. Biochem Biophys Res Commun 290:1506-1512.
5. Beninger RJ, Miller R. (1991). On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine. Prog Neurobiol 36:229-256.
6. Cameron DL, Crocker AD. (1989). Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist. Neurosci 32:769-778.
7. Campbell EL, Chebib M, Johnston GA. (2004). The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors. Biochem Pharmacol 68:1631-1648.
8. Chen WQ, Zhao XL, Hou Y, Li ST, Hong Y, Wang DL, et al. (2009). Protective effects of green tea polyphenols on cognitive impairments induced by psychological stress in rats. Behav Brain Res 202:71-76.
9. Choi YT, Jung CH, Lee SR, Bae JH, Back WK, Suh MH, et al. (2001). The green tea polyphenol (-)-epigallocatechin gallate attenuates b-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 70:603-614.
10. Choi JY, Ike DP, Choi JH, Yoon SY, Yim DS, Lee YS, et al. (2008). Psychopharmacological profile of the water extract of Gardenia jasminoides and its constituents, genipin and geniposide, in mice. Biomol Ther 16:118-125.
11. Daniel JC, Martin DS (1992). Psychostimulant-induced activity is attenuated by two putative dopamine release inhibitors pharmacology. Biochem Behav 43:1023-1031.
12. Delfs JM, Kelley AE. (1990). The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neurosci 39:59-67.
13. Dias FRC, Carey RJ, Carrera MP (2006). Conditioned locomotion induced by unilateral intrastriatal administration of Apomorphine: D2 receptor activation is critical but not the expression of the unconditioned response. Brain Res 1083:85-95.
14. Dwoskin LP, Peris J, Yasuda RP, Philpott K, Zahnister NR (1988). Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide. Life Sci 42:255-262.
15. Eun JS, Kwon HN, Hong JT, Oh KW (2006). Inhibitory effects of (-)-epigallocatechin gallate on morphine-induced locomotor sensitization and conditioned place preference in mice. J Applied Pharmacol 14:125-131.
16. Garrett BE, Griffiths RR (1997). The role of dopamine in the behavioral effects of caffeine in animals and humans. Biochem Pharmacol 531:533-541.
17. Haque AM, Hashimoto M, Katakura M, Hara Y, Shido O (2008). Green tea catechins prevent cognitive deficits caused by Ab1-40 in rats. J Nutr Biochem 19:619-626.
18. Jackson DM, Westlind-Danielsson A (1994). Dopamine receptors: Molecular biology, biochemistry and behavioural aspects. Pharmacol & Ther 64:291-370.
19. Kim CY, Lee C, Park GH, Jang HJ (2009). Neuroprotective effect of epigallocatechin-3-gallate against b-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Arch Pharm Res 32:869-881.
20. Mashurano M, Waddington JL (1986). Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393. Neuropharmacol 25:947-949.
21. Nehlig A, Daval J-L, Debry G (1992). Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17:139-170.
22. Porrino LJ, Domer FR, Crane AM, Sokoloff L (1988). Selective alternations in cerebral metabolism within mesocorticolimbic dopaminergic system produced by acute cocaine administration of rats. Neuropsychopharmacol 1:109-118.
23. Powell KR, Luvone PM, Holtzman SG (2001). The role of dopamine in locomotor stimulant effects and tolerance to these effects of caffeine. Pharmacol Biochem Behav 69:59-70.
24. Protais P, Costentin J, Schwartz JC (1976). Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptor in striatum. Psychopharmacol 50:1-6.
25. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, et al. (2005). Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25:8807-8814.
26. Sandoval MRL, Palermo-Neto J (1995). Effect of manipulation of the GABA system on dopamine-related behaviors. Braz J Med Biol Res 28:88-99.
27. Starr BS, Starr MS (1986). Grooming in the mouse is stimulated by the dopamine D1 agonist SKF38393 and by low doses of the D1 antagonist SCH23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH23390. Pharmacol Biochem Behav 24:837-839.
28. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H (1998). Wide distribution of [3H](-) epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19:1771-1776.
29. Ushijima I, Carino MA, Horita A (1995). Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats. Pharmacol Biochem Behav 52:737-741.
30. Vignes M, Maurice T, Lante F, Nedjar M, Thethi K, Guiramand J, et al. (2006). Anxiolytic properties of green tea polyphenol (-)-epigallocatethin gallate (EGCG). Brain Res 1110:102-115.
31. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.